Neuronetics, Inc. Stock Issued During Period, Value, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Neuronetics, Inc. stock issued during period, value, new issues for the quarter ending 2025-09-30 was $7.84M.
- Neuronetics, Inc. stock issued during period, value, new issues for the quarter ending 2025-03-31 was $18.97M, a 3727.10% increase year-over-year.
- Neuronetics, Inc. stock issued during period, value, new issues for the quarter ending 2024-03-31 was $495.65K, a 91.93% decline year-over-year.
- Neuronetics, Inc. stock issued during period, value, new issues for the quarter ending 2023-09-30 was $481.44K.
- Neuronetics, Inc. stock issued during period, value, new issues for fiscal 2021 was $80.57M.
- Neuronetics, Inc. stock issued during period, value, new issues for fiscal 2018 was $96.53M.
| Period end | Stock Issued During Period, Value, New Issues 3 month | Stock Issued During Period, Value, New Issues 12 month |
|---|---|---|
| 2025-09-30 | $7.84M 10-Q · filed 2025-11-04 | |
| 2025-03-31 | $18.97M 10-Q · filed 2025-11-04 | |
| 2024-03-31 | $495.65K 8-K/A · filed 2025-02-06 | |
| 2023-09-30 | $481.44K 8-K/A · filed 2025-02-06 | |
| 2023-03-31 | $6.14M 8-K/A · filed 2025-02-06 | |
| 2021-12-31 | $80.57M 10-K · filed 2024-03-08 | |
| 2021-03-31 | $80.57M 10-Q · filed 2022-11-08 | |
| 2018-12-31 | $96.53M 10-K · filed 2021-03-02 | |
| 2018-09-30 | $96.53M 10-Q · filed 2019-11-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Profound Medical Corp. (PROF) | $0.206B | -7.37 | |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| Lucid Diagnostics Inc. (LUCD) | United States | $0.170B | |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| KORU Medical Systems, Inc. (KRMD) | United States | $0.151B | -106.78 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |